6649-91-8
6649-91-8
Chemical Structure
1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid
- CAS No.: 6649-91-8
- Formula:C12H12N2O2
- Molecular Weight:216.24
IUPAC Name: 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-1-carboxylic acid
InChIKey: XGCIVVYTCDKDLC-UHFFFAOYSA-N
SMILES: OC(C1NCCC2=C1NC3=C2C=CC=C3)=O
Biological Activity: 1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid is a chemical used on the study of neurodegenerative diseases[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid | 99.48% | 1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid is a chemical used on the study of neurodegenerative diseases. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Lycoperodine-1 | 99.82% | Lycoperodine-1 (Cyclomethyltryptophan) is an active product that can be isolated from tomato fruits (Lycopersicon sculentum). Lycoperodine-1 act as an agonist of Ca2+ sensing receptors (CaSR). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PDI-IN-3 | 98.69% | PDI-IN-3 (compound 16F16) is a protein disulfide isomerase (PDI) inhibitor. PDI-IN-3 inhibits cell viability. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Tetrahydroharmine | 99.61% | Tetrahydroharmine (Leptaflorine) is a selective reversible monoamine oxidase A (MAO-A) inhibitor with an IC50 of 74 nM. Tetrahydroharmine can be used for the research of parkinson’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Selisistat | 99.92% | Selisistat (EX-527) is a potent and selective SirT1 (Sir2 in Drosophila melanogaster) inhibitor with an IC50 of 123 nM for SirT1. Selisistat alleviates pathology in multiple animal and cell models of Huntington's disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(S)-Selisistat | 99.39% | (S)-Selisistat ((S)-EX-527) is a potent and selective SIRT1 inhibitor, with an IC50 of 98 nM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fenharmane | Fenharmane is a serotonin 2B (5HT2B) receptor antagonist. Fenharmane blocks serotonin-induced contractions mediated by 5HT2B receptors in isolated strips of rat fundus smooth muscle. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Antifibrotic agent 3 | Antifibrotic agent 3 is an orally active antifibrotic agent. Antifibrotic agent 3 reduces hepatic stellate cell activation by downregulating the expression of Collagen I and α-SMA. Antifibrotic agent 3 inhibits liver fibrosis in bile duct ligation and carbon tetrachloride-induced liver fibrosis models. Antifibrotic agent 3 can be used for the research of liver fibrosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Komaroidine | Komaroidine is a bactericidal agent. Komaroidine induces reactive oxygen species (ROS) bursts in bacterial cells, disrupts antioxidant enzyme function and redox homeostasis, increases membrane permeability, and triggers bacterial apoptosis. Komaroidine suppresses bacterial burden within infected plant tissues.Komaroidine exhibits broad-spectrum antibacterial activity against phytopathogenic bacteria including Xanthomonas oryzae pv. oryzae, Xanthomonas axonopodis pv. citri, and Pseudomonas syringae pv. actinidiae. Komaroidine can be used for the research of rice bacterial leaf blight. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
(-)-(1S,3S)-MTCA | (-)-(1S,3S)-MTCA can be isolated from Japanese soy sauce. (-)-(1S,3S)-MTCA induces revertants of Salmonella typhimurium TA100, after treatment with nitrite. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
H-D-Tpi-OH | H-D-Tpi-OH (D-1,2,3,4-Tetrahydronorharman-3-carboxylic acid) is a tetrahydro-β-carboline derivative. H-D-Tpi-OH only slightly upregulates QR1, mildly inhibits the aromatase and NO synthesis pathways, and shows no significant in vitro anti-breast tumor proliferation activity. H-D-Tpi-OH can be used in cancer-related research. |
|||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
